Related references
Note: Only part of the references are listed.mTOR and Tumor Cachexia
Adrian P. Duval et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study
Miranda M. Fidler et al.
LANCET ONCOLOGY (2017)
mTOR inhibition improves the immunomodulatory properties of human bone marrow mesenchymal stem cells by inducing COX-2 and PGE2
Binsheng Wang et al.
STEM CELL RESEARCH & THERAPY (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging
Brian K. Kennedy et al.
CELL METABOLISM (2016)
mTOR signaling in osteosarcoma: Oncogenesis and therapeutic aspects (Review)
Kai Hu et al.
ONCOLOGY REPORTS (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Cullin1 is a novel prognostic marker and regulates the cell proliferation and metastasis in colorectal cancer
Weimin Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Role of LKB1-CRTC1 on Glycosylated COX-2 and Response to COX-2 Inhibition in Lung Cancer
Chunxia Cao et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Cell-type-specific roles for COX-2 in UVB-induced skin cancer
Jing Jiao et al.
CARCINOGENESIS (2014)
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Mitsugu Shimobayashi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Phenolcarboxylic acids from medicinal herbs exert anticancer effects through disruption of COX-2 activity
Li Tao et al.
PHYTOMEDICINE (2014)
Cullin1 is a novel marker of poor prognosis and a potential therapeutic target in human breast cancer
J. Bai et al.
ANNALS OF ONCOLOGY (2013)
The Association between COX-2 Polymorphisms and Hematologic Toxicity in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Platinum-Based Chemotherapy
Fei Zhou et al.
PLOS ONE (2013)
Prognostic and Predictive Role of JWA and XRCC1 Expressions in Gastric Cancer
Shouyu Wang et al.
CLINICAL CANCER RESEARCH (2012)
The hairless mouse in skin research
Fernando Benavides et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2009)
The global health burden of infection -associated cancers in the year 2002
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CANCER (2006)
Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2
SF Kim et al.
SCIENCE (2005)
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer
AJ Dannenberg et al.
LANCET ONCOLOGY (2001)
Share Paper
